Across Europe, medical wellness and longevity therapies are becoming increasingly popular as people search for safe and effective ways to improve energy, metabolism, and long-term weight management. Treatments such as NAD+ injections, Sermorelin peptide therapy, and Semaglutide weight-loss programmes are now available in leading clinics across the UK, Germany, Spain, and France, providing modern solutions to common health and metabolic challenges.

NAD+ Injections in Europe: Cost and Benefits

Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme found in every cell of the body, responsible for energy production and DNA repair. As we age, NAD+ levels naturally decline, leading to fatigue, slower metabolism, and cognitive sluggishness. Restoring these levels through NAD+ injections helps increase energy, improve focus, promote recovery from stress or jet lag, and support healthy aging.

In Europe, the cost of NAD+ therapy varies by country and clinic. In the United Kingdom, a single session may cost between Ł200 and Ł450, while in Germany, France, or Spain, prices typically range from €250 to €500 per session. Many wellness centres offer monthly programmes costing between €600 and €1,000, and some also provide home injection kits under for added convenience.

Sermorelin Peptide Therapy in Europe

Sermorelin acetate is a peptide that stimulates the natural production of growth hormone by the pituitary gland. Unlike synthetic HGH, which is tightly regulated in the EU, Sermorelin safely encourages the body’s own growth hormone production, helping to maintain hormonal balance.

Patients often turn to Sermorelin therapy to combat low energy, poor sleep, and reduced metabolism. The treatment may improve muscle tone, promote fat loss, enhance recovery, and rejuvenate the skin by boosting collagen production. Sermorelin therapy is available through anti-aging or longevity clinics in many major European cities, with an average monthly cost of €200 to €400. Initial blood tests and consultations may add an additional €100 to €200. Many patients combine Sermorelin with NAD+ or vitamin infusions for a more comprehensive rejuvenation effect.

The Semaglutide Plateau: Why Weight Loss Slows Down

Semaglutide—available under names such as Ozempic®, Wegovy®, or Rybelsus®—is approved across the EU and the UK for managing obesity and type 2 diabetes. It mimics the GLP-1 hormone to help control appetite, reduce cravings, and improve blood sugar balance. Most patients experience significant weight loss during the first few months of treatment, but eventually, many encounter a slowdown known as the Semaglutide plateau.

This plateau occurs as the body adapts to reduced calorie intake, metabolism slows, and hormonal responses shift. In some cases, the same dose becomes less effective over time, or the loss of muscle mass leads to lower energy expenditure. Overcoming this stage often involves reviewing dosage, adjusting nutrition, and incorporating strength-based exercise to preserve lean muscle. Some clinics recommend combining Semaglutide with Sermorelin or NAD+ to boost metabolism and energy, which can help patients break through the plateau.

Today, many European clinics offering GLP-1 therapy include comprehensive support programmes with nutrition, metabolic assessments, and peptide combinations to ensure continued progress.


Key Insights

NAD+ injections help restore cellular energy and cognitive performance, Sermorelin therapy optimises natural growth hormone production and enhances metabolism, while Semaglutide provides an effective medical option for weight management—although plateaus can occur. When combined and supervised by experienced clinicians, these treatments can deliver balanced, sustainable results that promote energy, longevity, and overall wellbeing.

Disclaimer

All treatments described require professional consultation and a valid . Availability and regulations vary across the EU and the UK. Individual results depend on medical history, dosage, and adherence to provider recommendations.